NO20003075L - Neurobeskyttende midler - Google Patents

Neurobeskyttende midler

Info

Publication number
NO20003075L
NO20003075L NO20003075A NO20003075A NO20003075L NO 20003075 L NO20003075 L NO 20003075L NO 20003075 A NO20003075 A NO 20003075A NO 20003075 A NO20003075 A NO 20003075A NO 20003075 L NO20003075 L NO 20003075L
Authority
NO
Norway
Prior art keywords
sup
group
aryl
alkyl
formula
Prior art date
Application number
NO20003075A
Other languages
English (en)
Other versions
NO20003075D0 (no
Inventor
Mark Bradley
Fausto Iannotti
Ashley Ker Pringle
Lars Eric Sundstrom
Original Assignee
Univ Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southampton filed Critical Univ Southampton
Publication of NO20003075D0 publication Critical patent/NO20003075D0/no
Publication of NO20003075L publication Critical patent/NO20003075L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
NO20003075A 1997-12-16 2000-06-15 Neurobeskyttende midler NO20003075L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726569.8A GB9726569D0 (en) 1997-12-16 1997-12-16 Neuroprotective agents
PCT/GB1998/003775 WO1999031049A1 (en) 1997-12-16 1998-12-16 Neuroprotective agents

Publications (2)

Publication Number Publication Date
NO20003075D0 NO20003075D0 (no) 2000-06-15
NO20003075L true NO20003075L (no) 2000-08-15

Family

ID=10823695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003075A NO20003075L (no) 1997-12-16 2000-06-15 Neurobeskyttende midler

Country Status (19)

Country Link
US (2) US6797699B1 (no)
EP (1) EP1040096B1 (no)
JP (1) JP2002508349A (no)
KR (1) KR20010033249A (no)
CN (1) CN1284058A (no)
AT (1) ATE244698T1 (no)
AU (1) AU739296B2 (no)
CA (1) CA2315258C (no)
DE (1) DE69816337T2 (no)
DK (1) DK1040096T3 (no)
ES (1) ES2201563T3 (no)
GB (1) GB9726569D0 (no)
HU (1) HUP0004486A3 (no)
IL (1) IL136800A (no)
NO (1) NO20003075L (no)
NZ (1) NZ505110A (no)
PT (1) PT1040096E (no)
RU (1) RU2205177C2 (no)
WO (1) WO1999031049A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7312244B2 (en) 1999-04-30 2007-12-25 Cellgate, Inc. Polyamine analog-amino acid conjugates useful as anticancer agents
GB2363983A (en) 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
HRP20040784A2 (en) 2002-01-29 2005-04-30 Wyeth Compositions and methods for modulating connexin hemichannels
GB0202645D0 (en) * 2002-02-05 2002-03-20 Univ Southampton Treatment of chronic neurodegenerative diseases
WO2008105441A1 (ja) * 2007-02-27 2008-09-04 Ajinomoto Co., Inc. リン吸収抑制活性を有するポリアミノ酸化合物及びリン吸収抑制剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2465303A (en) * 1939-04-03 1949-03-22 Research Corp Lactones
EP0241797B1 (en) * 1986-04-04 1991-06-12 Microbial Chemistry Research Foundation Novel spergualin-related compounds and process for producing the same
US6262125B1 (en) * 1986-12-02 2001-07-17 University Of Florida Research Foundation, Inc. Sterically hindered tetraamines and method for their production
US5242947A (en) 1988-02-10 1993-09-07 New York University Use of polyamines as ionic-channel regulating agents
SK279476B6 (sk) * 1989-05-17 1998-11-04 Pfizer Deriváty 2-piperidino a 2-pyrolidino-1-alkanolov a
EP0597830A1 (en) * 1989-07-03 1994-05-25 New York University Nyu Medical Center Use of polyamines as ionic-channel regulating agents
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
SE9302334D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
SE9302332D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
SE9302333D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
FR2773798B1 (fr) 1998-01-16 2001-02-02 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EP1040096B1 (en) 2003-07-09
CA2315258C (en) 2008-07-15
DK1040096T3 (da) 2003-10-20
DE69816337T2 (de) 2004-04-15
CN1284058A (zh) 2001-02-14
DE69816337D1 (de) 2003-08-14
NZ505110A (en) 2003-01-31
PT1040096E (pt) 2003-09-30
IL136800A0 (en) 2001-06-14
IL136800A (en) 2005-07-25
HUP0004486A3 (en) 2002-11-28
AU739296B2 (en) 2001-10-11
KR20010033249A (ko) 2001-04-25
HUP0004486A2 (hu) 2001-05-28
EP1040096A1 (en) 2000-10-04
ES2201563T3 (es) 2004-03-16
CA2315258A1 (en) 1999-06-24
US7026297B2 (en) 2006-04-11
JP2002508349A (ja) 2002-03-19
WO1999031049A1 (en) 1999-06-24
US20040106560A1 (en) 2004-06-03
AU1571799A (en) 1999-07-05
US6797699B1 (en) 2004-09-28
RU2205177C2 (ru) 2003-05-27
GB9726569D0 (en) 1998-02-11
HK1029331A1 (en) 2001-03-30
NO20003075D0 (no) 2000-06-15
ATE244698T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
BR9106819A (pt) Polimeros contendo unidades diester,processo para a preparacao de um polimero e compostos
CA2078790A1 (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
ES2187473T3 (es) Triarylimidazoles.
CA2203237A1 (en) Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
CA2325741A1 (en) Urea derivatives having tnf- .alpha. production inhibitory effects
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
CA2200316A1 (en) Imidazole derivative
CA2057786A1 (en) Amino and nitro containing tricyclic compounds useful as inhibitors or ace
EP1184373A4 (en) TRICYCLIC CONNECTIONS
NO20003773L (no) Syklobutenderivater, deres fremstilling og deres terapeutiske anvendelser
CA2045857A1 (en) Diaminotrifluoromethylpyridine Derivatives, Process for Their Production and Phospholipase A2 Inhibitor Containing Them
DK1040096T3 (da) Neurobeskyttende midler
ES2021182A6 (es) Procedimiento para preparar derivados de capsaicina.
ES2044781A1 (es) Procedimiento para la preparacion de nuevas amidas con accion inhibidora de la fosfolipasa a2
EP0567090A3 (no)
FR2672213B1 (fr) Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
ATE172749T1 (de) Waschmittelzusammensetzungen zur verhinderung der farbstoffübertragung
WO2000063222A3 (fr) Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
DE68927554D1 (de) Cephalosporinverbindungen und Verfahren zu ihrer Herstellung
DE69007356D1 (de) Zyklisches Tetrapeptid und Verfahren zu dessen Herstellung.
KR940000445A (ko) 페닐-1,2,5-옥사디아졸카복스아미드-2-옥사이드
ATE36705T1 (de) Arzneimittel auf basis von piperidinderivaten, piperidinderivate und verfahren zu ihrer herstellung.
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
MX9702089A (es) Carboxamidas biciclicas como antagonistas de 5-ht1a.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application